Large molecule bioanalytical services and toxicology testing

Smithers Avanza is a contract research organization (CRO) supporting the pharmaceutical, agrochemical, and chemical industries.  Our scientists have expertise in large molecule bioanalysis, assay development, validation and sample analysis at our GLP- and GCP-compliant and CLIA registered laboratory.  We offer preclinical toxicology and vaccine testing at our AAALAC accredited facilities.

Smithers Avanza Bioanalytical Services supports the development of biologics and vaccines from discovery through phase IV, with expertise that includes bioassays and high sensitivity assays.  The services focus primarily on development, validation and sample analysis for PK/TK, ADA, bioassays and biomarker assays.

Smithers Avanza Toxicology Services supports pharmaceutical and agrochemical development through the identification of safety and/or efficacy outcomes.  Studies are conducted across multiple species.  Our key expertise includes single dose to two-year general toxicology studies, vaccine safety testing, toxicokinetics, and infusion studies.







  • Visit the Bioanalytical Services team in booth #317 during the AAPS-NBC meeting in San Francisco, June 8-10. Dr. Phyllis Conliffe, Executive Director of Bioanalytical Services, will be presenting a poster titled, “Evaluation of a Multiplexed Anti Drug Antibody (ADA) Assay for Immunogenicity Testing in Support of Combination Biologic Therapies.” The poster session will be held in the Yerba Buena Ballroom 9-15 Monday, June 8 from 10:00am to 6:30pm.  
  • Dr. Phyllis Conliffe presented during the GEN webinar Single Molecule Counting Technology: Beyond ELISA for Ultrasensitive Immunoassay Development. View the webinar.
  • Preclinical Vaccine Safety Studies Webinar: Solutions to Development Obstacles. Contact us to receive a link to the vaccine safety testing webinar recording. Learn more about our vaccine safety testing capabilities.